Updates on Triple-Negative Breast Cancer in Type 2 Diabetes Mellitus Patients: From Risk Factors to Diagnosis, Biomarkers and Therapy

Triple-negative breast cancer (TNBC) is usually the most malignant and aggressive mammary epithelial tumor characterized by the lack of expression for estrogen receptors and progesterone receptors, and the absence of epidermal growth factor receptor (HER)2 amplification. Corresponding to 15–20% of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Matou-Nasri, Sabine, Aldawood, Maram, Alanazi, Fatimah, Khan, Abdul Latif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378597/
https://www.ncbi.nlm.nih.gov/pubmed/37510134
http://dx.doi.org/10.3390/diagnostics13142390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378597/
https://www.ncbi.nlm.nih.gov/pubmed/37510134
http://dx.doi.org/10.3390/diagnostics13142390

Ejemplares similares